Gout and SGLT2 Inhibitors: Evidence Points to Reduced Need for ULT, Flare DrugsNovember 19, 2024DiabetesNephrologyCardiologyRheumatology
Need for Low-Dose Steroids to Prevent Relapse in GPA Vasculitis Depends on Treatment RegimenNovember 18, 2024Rare DiseasesRheumatologyNephrologyPulmonology
First Phase 3 Drug Trial in IgG4-Related Disease Has SuccessNovember 18, 2024NephrologyGastroenterologyNeurologyRheumatologyRare DiseasesPulmonology
Abuse of the Safety-Net 340B Drug Pricing Program: Why Should Physicians Care?November 18, 2024Business of MedicineRheumatologyGastroenterologyOncology
Late-Onset Axial Spondyloarthritis: How Does It Differ From Early-Onset Disease?November 11, 2024Rheumatology
Scurvy: A Diagnosis Still Relevant TodayNovember 8, 2024GastroenterologyRare DiseasesDermatologyAnemiaHematologyRheumatologyNeurology
Novel Treatment Promising for Cutaneous Lupus in Phase 2 TrialNovember 4, 2024DermatologyRheumatology
What’s the Evidence Behind Popular Supplements in Rheumatology? Experts Weigh inNovember 4, 2024PainRheumatology
Total Hip Replacement Superior to Exercise Therapy for Improving Hip Osteoarthritis Pain and FunctionOctober 31, 2024Rheumatology
Extended-Release Fluticasone Injection Successful in Phase 2 Knee OA TrialOctober 29, 2024Rheumatology
Therapeutic Drug Monitoring in Rheumatology: A Promising Outlook But Many Barriers to OvercomeOctober 23, 2024Rheumatology
